EyeCyte Company

EyeCyte is engaged in the development of therapeutics for the treatment of neovascular and degenerative retinal diseases.

Last Funding Type: Series A
Funding Status: Early Stage Venture
Headquarters: La Jolla, California, United States
Founded Date: 2005
Investor Type: N/A
Investment Stage: N/A
Total Funding: $3M
Technology: Small Molecules
Employee Number: 1-10
Number Of Exists: N/A
Estimated Revenue: $1M to $10M
Investors Number: 1
Industry: PharmTech